Purchase Order 75N90025P00656
Award Date
9/15/25
Potential Completion Date
9/14/26
Potential Value
$44K
Federal Agency
NIH Clinical Center
Awardee
Karius, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Redwood City, CA 94065, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the National Institutes of Health (NIH) Clinical Center to Karius, Inc., a life sciences company specializing in diagnostic testing for infectious diseases. The contract, valued at $80,000.00, is for the provision of molecular diagnostic testing services using Karius' liquid biopsy technology to rapidly screen patients for various pathogens. The testing services will be delivered within 3-4 days of specimen receipt. This is a firm fixed-price purchase order...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to Karius, Inc. for the provision of next-generation sequencing (NGS) tests. The contract, valued at $120,000.00, has an ultimate completion date of July 31, 2025. Karius, Inc. is the sole source provider of these specialized NGS tests for the VA VHA, as the agency determined the company to be the only responsible source capable of meeting its requirements. This...
This is a federal contract award to Karius, Inc., a life sciences company specializing in next-generation sequencing (NGS) and molecular diagnostic testing services. The contract, awarded by the U.S. Department of Veterans Affairs (VA), is an Indefinite Delivery Contract (IDC) valued at up to $120,000,000. Under this IDC, the VA can purchase Karius' KARIUS NEXT GENERATION SEQUENCING TEST at $2,000 per test, with Karius identified as the sole responsible source. The contract has a period of...
This is a firm fixed price purchase order awarded by the Defense Health Agency (DHA) to Karius, Inc. for quantitative next-generation sequencing testing services. The $240,000 contract supports DHA programs through September 2023 and leverages Karius' expertise in genomic sequencing to rapidly screen patients for various pathogens. This is a sole source award, as Karius is the only commercial laboratory capable of providing the requested cell-free DNA testing from plasma samples with 24-72...
The Department of the Navy Bureau of Medicine and Surgery awarded a $140,000 firm fixed price purchase order to Karius, Inc. for the provision of 70 quantitative next generation sequencing tests. This award is not associated with a larger contract vehicle and does not have a set-aside designation. Karius, Inc. is a life sciences company focused on diagnostic testing for infectious diseases. The purchase order supports Department of Defense programs through September 2027 and leverages Karius'...
This federal contract award is to Karius, Inc., a life sciences company specializing in diagnostic science and technology for infectious diseases. The $240,000.00 Purchase Order contract is for the provision of a Quantitative Next-Gen Sequencing Test to the Defense Health Agency, a defense agency. The contract has a period of performance through September 30, 2027 and was awarded on a Firm Fixed Price basis without any set-aside designation. Karius, Inc. has secured multiple prior federal...
The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 has awarded Karius, Inc. a firm-fixed-price delivery order contract for its Karius Next Generation Sequencing (NGS) diagnostic test. The contract has a ceiling value of $60,000 and a performance period from August 1, 2023 to July 31, 2024. This award is part of a larger $600,000 Indefinite Delivery Contract (IDC) that Karius holds with the VA VHA, which has an ultimate completion date of July 31, 2027. The...
The Defense Health Agency (DOD) awarded a $250,000 firm fixed price purchase order to Karius, Inc., doing business as Karius Inc., located in San Diego, California. The contract is for Quantitative Next-Gen Sequencing Testing Services and has a period of performance from October 1, 2022 through September 30, 2023. Karius provides genomic sequencing and bioinformatics analysis services to identify pathogens and monitor antimicrobial resistance. No applicable subcontractors were identified in...
This is a firm-fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Karius, Inc., a life sciences company based in Redwood City, California. The contract, valued at $630,976.00, is for research and development related to metagenomic sequencing of microbial cell-free DNA and RNA for comprehensive pathogen detection. This contract does not have a set-aside designation, indicating Karius competed as a...
This firm-fixed-price purchase order was awarded by the Department of Health and Human Services National Institutes of Health (NIH) Clinical Center to Miravista Diagnostics LLC, a for-profit limited liability company that manufactures goods and provides clinical laboratory testing services. The $43,000.00 contract is for fungal testing services and has a completion date of March 21, 2025. Miravista Diagnostics has experience providing specialized laboratory services, including microbiology...